Endocrine Abnormalities During the Follicular Phase in Women with Recurrent Spontaneous Abortion
Overview
Authors
Affiliations
The frequency of endocrine abnormalities during the follicular phase in non-pregnant women with a history of recurrent abortion was investigated in a case-control study. A total of 42 consecutive women with recurrent spontaneous abortion (three or more consecutive abortions, mean +/- SD: 3.9 +/- 1.1 range 3-8) with no parental chromosome rearrangement or uterine abnormality were studied during the early follicular phase under standardized conditions. Serum concentrations of follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin, androstenedione, testosterone, dehydroepiandro-stenedione, 17-OH-progesterone, oestradiol, progesterone and thyroid stimulating hormone (TSH) were measured by commercially available radioimmunoassays. Controls were 42 nulligravid females with tubal or male factor infertility without miscarriage. Mean (SD) concentrations of prolactin and androstenedione were 14.2 +/- 6.7 ng/ml versus 10.5 +/- 3.5 ng/ml (95% CI 0.8-6.1) and 2.3 +/- 0.9 ng/ml versus 1.7 +/- 0.6 ng/ml (95% CI 0.2-0.9) in the study and control groups respectively. The other endocrine parameters were comparable in both groups. Obesity [BMI weight (kg)/height (m2) > or = 25] was more prevalent (23 versus 5 women, P = 0.0001) in the study than the control group. Recurrent spontaneous abortion is associated with abnormalities in prolactin and androgen secretion during the follicular phase, suggesting an endocrine aetiology in this disorder. Reduction of body weight and correction of hyperprolactinaemia and of hyperandrogenism may reduce the rate of miscarriage in a subsequent pregnancy in these women.
Androgens modulate endometrial function.
Yamagata K, Mizuno Y, Mizuno Y, Tamaru S, Kajihara T Med Mol Morphol. 2025; .
PMID: 40063300 DOI: 10.1007/s00795-025-00430-6.
Williams A, Hossack D, Thompson N, Sim Y, Wilson C, Schuch V Front Immunol. 2025; 15:1496610.
PMID: 39763651 PMC: 11701216. DOI: 10.3389/fimmu.2024.1496610.
Orosz M, Borics F, Ratonyi D, Vida B, Csehely S, Jakab A Diagnostics (Basel). 2024; 14(19).
PMID: 39410647 PMC: 11476020. DOI: 10.3390/diagnostics14192241.
Australasian Recurrent Pregnancy Loss Clinical Management Guideline 2024 Part I.
Suker A, Li Y, Robson D, Marren A Aust N Z J Obstet Gynaecol. 2024; 64(5):432-444.
PMID: 38934264 PMC: 11660023. DOI: 10.1111/ajo.13821.
Toth E, Gyorffy D, Posta M, Hupuczi P, Balogh A, Szalai G Int J Mol Sci. 2024; 25(3).
PMID: 38339143 PMC: 10855863. DOI: 10.3390/ijms25031865.